Items tagged with Access
New Global Drug Facility communications listserv (post)
The Stop TB Partnership's Global Drug Facility now has a special communications channel dedicated to Procurement & Supply Management issues.
EU Commissioner signals support for LDC request to waive IP rights enforcement on pharma (post)
European Trade Commissioner Cecilia Malmström said in a recent speech that providing she has the backing of the College of Commissioners, the Council and the European Parliament, she would like to answer positively to the request by least developed countries (LDCs) to extend a particular exemption to enforce intellectual property rights on medical products as long as they remain an LDC.
MSF: TPP negotiators must fix the most damaging trade agreement ever for global health (post)
Maui/New York, July 24, 2015—Trade negotiators must remove damaging access to medicines provisions in the Trans-Pacific Partnership (TPP) trade deal or risk locking in high drug prices and endangering the health of millions of people for decades to come, said the medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) as negotiations resumed in Maui, Hawaii, today. MSF’s call comes as reports indicate that this could be the last negotiation before the agreement is concluded.
Ambitious new U.S. plan may put hundreds of thousands on MDR-TB treatment (post)
The United States plans to place 360,000 multidrug-resistant tuberculosis patients globally on treatment over the next five years, as part of a national tuberculosis action plan currently under draft. The plan – which is due to be submitted to the White House in September – aims to promote universal MDR-TB treatment, accelerate basic TB research, and strengthen domestic capacity to combat MDR-TB, according to Administration officials who discussed the action plan with stakeholders in July.
NGOs cry foul at drug patent rules in TPP (post)
The international pharmaceutical industry is under renewed attack for squeezing trading partners into tight intellectual property rights requirements.
Patents: A question of utility (post)
Patents are protected by governments because they are held to promote innovation. But there is plenty of evidence that they do not.
test (post)
test
European Commission supports better access to medicines in poorest countries (post)
The Commission today (September 10) agreed to support the least developed countries' (LDCs) call for easier access to cheaper medicines by means of an indefinite exemption from World Trade Organization (WTO) intellectual property rules for pharmaceuticals. This exemption allows generic medicines to be imported, and produced locally, regardless of patents, for example when licenses are not available. It means producers of generics and international programmes can supply drugs like HIV treatment in affected countries without fear of patent infringement suits.
Health advocates press United States on WTO LDC IP waiver (post)
Several leading public health groups have sent a letter to United States Trade Representative and US Patent and Trademark Office director asking for more transparency on the US position on a request by least-developed countries to indefinitely extend their World Trade Organization intellectual property waiver on pharmaceutical products.
US: Drug goes from $13.50 a tablet to $750, overnight (post)
Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection.
Page 14 of 83 · Total posts: 0
←First 13 14 15 Last→